Edgewise Therapeutics, Inc. (EWTX)

CIK 1710072 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Edgewise Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 17, 20264/A0001644087-26-000006
Aug 17, 20264/A0001853529-26-000003
Aug 17, 20264/A0001853109-26-000002
Aug 17, 20264/A0001705477-26-000002
Aug 17, 20264/A0001191702-26-000002
Aug 14, 202640001185829-26-000001
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097206
Aug 14, 202640001705477-26-000001
Aug 14, 202640001191702-26-000001
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097041
Aug 14, 202640001644087-26-000005
Aug 14, 202640001853109-26-000001
Aug 14, 202640001853529-26-000002
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000922
Aug 13, 20261440001950047-26-008084
Aug 6, 202610-Q0001104659-26-091670
Aug 6, 2026SCHEDULE 13G0000315066-26-001979
Aug 6, 20268-K0001104659-26-091671
Jul 17, 202640001710072-26-000001
Jul 16, 20268-K/A0001104659-26-084088
Jul 13, 20268-K0001104659-26-082902
Jul 2, 202640001853529-26-000001
Jul 1, 202640001655016-26-000004
Jul 1, 20261440001950047-26-006753
Jun 17, 202640001357522-26-000001